Acceder Registro /

Cecilia María Herraiz Serrano

Buscador

Abrisqueta M, Cerdido S, Sanchez-Beltran J, Martinez-Vicente I, Herraiz C, Lambertos A, Olivares C, Sevilla A, Alonso S, Boyano MD, Garcia-Borron JC, Jimenez-Cervantes C. MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker. Life (Basel). 2022 Jul 26;12(8):1118. doi: 10.3390/life12081118. PubMed PMID: 35892921; PubMed Central PMCID: PMC9331370.
AÑO: 2022; IF: 3.251
Herraiz C, Martínez-Vicente I, Maresca V. The α-melanocyte-stimulating hormone/melanocortin-1 receptor interaction: A driver of pleiotropic effects beyond pigmentation. Pigment Cell Melanoma Res. 2021 Jul;34(4):748-761. doi: 10.1111/pcmr.12980. Epub 2021 May 2. Review. PubMed PMID: 33884776.
AÑO: 2021; IF: 4.159
Martínez-Vicente I, Abrisqueta M, Herraiz C, Jiménez-Cervantes C, García-Borrón JC, Olivares C. Functional characterization of a C-terminal splice variant of the human melanocortin 1 receptor. Exp Dermatol. 2020 Jul;29(7):610-615. doi: 10.1111/exd.14118. Epub 2020 Jun 15. PubMed PMID: 32474972.
AÑO: 2020; IF: 3.96
Martínez-Vicente I, Abrisqueta M, Herraiz C, Sirés-Campos J, Castejón-Griñán M, Bennett DC, Olivares C, García-Borrón JC, Jiménez-Cervantes C. Mahogunin Ring Finger 1 Is Required for Genomic Stability and Modulates the Malignant Phenotype of Melanoma Cells. Cancers (Basel). 2020 Oct 1;12(10). pii: E2840. doi: 10.3390/cancers12102840. PubMed PMID: 33019669; PubMed Central PMCID: PMC7599452.
AÑO: 2020; IF: 6.575
Georgouli M, Herraiz C, Crosas-Molist E, Fanshawe B, Maiques O, Perdrix A, Pandya P, Rodriguez-Hernandez I, Ilieva KM, Cantelli G, Karagiannis P, Mele S, Lam H, Josephs DH, Matias-Guiu X, Marti RM, Nestle FO, Orgaz JL, Malanchi I, Fruhwirth GO, Karagiannis SN, Sanz-Moreno V. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell. 2019 Feb 7;176(4):757-774.e23. doi: 10.1016/j.cell.2018.12.038. Epub 2019 Jan 31. PubMed PMID: 30712866; PubMed Central PMCID: PMC6370915.
AÑO: 2019; IF: 38.637

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R